Medical Abortion
Conditions
Brief summary
This study aims to investigate the effectiveness and acceptability of the multi-level pregnancy test for self-assessment of abortion outcomes, without a routine provider contact.
Interventions
Patients enrolled into the study will do a multi-level pregnancy test (MLPT) at enrollment, and will receive one MLPT to do at home one week after taking mifepristone and misoprostol. They will be instructed to call the study site if the at-home MLPT result do not decline, or if they experience any abortion complications.
Sponsors
Study design
Eligibility
Inclusion criteria
* Gestational age of less than or equal to 63 days * Determined by the site investigator or designee to be fully eligible for medical abortion with mifepristone followed by misoprostol according to the site's standard criteria * Willing to use the MLPT at home * 11-56 years old * Willing and able to comply with study procedures * In the judgement of the site investigator, she is capable of giving informed consent and she has signed the study informed consent or assent form
Exclusion criteria
\-
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Proportion of subjects who fail to contact the clinic when indicated within two weeks after taking the mifepristone | One month |
Countries
United States